Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 2
2007 5
2008 3
2009 12
2010 7
2011 12
2012 10
2013 12
2014 8
2015 5
2016 9
2017 14
2018 9
2019 9
2020 15
2021 10
2022 8
2023 9
2024 8
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

149 results

Results by year

Filters applied: . Clear all
Page 1
How I Evaluate and Treat Resistance and Relapse in CML.
Soverini S, Castagnetti F. Soverini S, et al. Among authors: castagnetti f. Blood. 2025 May 15:blood.2024026511. doi: 10.1182/blood.2024026511. Online ahead of print. Blood. 2025. PMID: 40373278
Real-World Efficacy Profile of Compassionate Use of Asciminib in an Italian, Multi-Resistant Chronic-Phase Chronic Myeloid Leukemia (CML-CP) Patient Population.
Breccia M, Rossi AR, Giai V, Martino B, Fava C, Annunziata M, Abruzzese E, Binotto G, Baratè C, Nardozza AP, Misto A, Coco P, Calafiore V, Carraro MC, Cattina F, Cavazzini F, Corsetti MT, Crucitti L, Crugnola M, Di Veroli A, Ditonno P, Ermacora A, Ferrara F, Genua A, Gozzini A, Impera S, Iurlo A, Levato L, Luciano L, Miggiano MC, De Gobbi M, Santoro M, Scappini B, Scortechini AR, Patriarca A, Rosati S, Russo S, Sancetta R, Sanpaolo G, Santeramo TM, Sibilla S, Sorà F, Sportoletti P, Stagno F, Trabacchi E, Castagnetti F. Breccia M, et al. Among authors: castagnetti f. Hematol Oncol. 2025 May;43(3):e70101. doi: 10.1002/hon.70101. Hematol Oncol. 2025. PMID: 40344674 Free PMC article.
Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies.
Sicuranza A, Breccia M, Iuliano F, Gugliotta G, Castagnetti F, Lunghi M, Patriarca A, Intermesoli T, Luciano L, Russo Rossi A, Rege Cambrin G, Vucinic V, Malagola M, Malato A, Abruzzese E, D'Adda M, Galimberti S, Defina M, Sammartano V, Cafarelli C, Cencini E, Cartocci A, Pacelli P, Piciocchi A, Rughini A, Niederwieser D, Bocchia M. Sicuranza A, et al. Among authors: castagnetti f. Vaccines (Basel). 2025 Apr 16;13(4):419. doi: 10.3390/vaccines13040419. Vaccines (Basel). 2025. PMID: 40333294 Free PMC article.
SETD2 loss of function is a recurrent event in advanced-phase chronic myeloid leukemia and contributes to genomic instability: SETD2 loss in Chronic Myeloid Leukemia.
Mancini M, De Santis S, Monaldi C, Castagnetti F, Iezza M, Iurlo A, Cattaneo D, Galimberti S, Cerrano M, Capodanno I, Bonifacio M, Rossi M, Agostinelli C, Meggendorfer M, Haferlach T, Cavo M, Gugliotta G, Soverini S. Mancini M, et al. Among authors: castagnetti f. Clin Transl Med. 2025 Apr;15(4):e70163. doi: 10.1002/ctm2.70163. Clin Transl Med. 2025. PMID: 40275711 Free PMC article.
Deep Molecular Response Rate in Chronic Phase Chronic Myeloid Leukemia: Eligibility to Discontinuation Related to Time to Response and Different Frontline TKI in the Experience of the Gimema Labnet CML National Network.
Breccia M, Cucci R, Marsili G, Castagnetti F, Galimberti S, Izzo B, Sorà F, Soverini S, Messina M, Piciocchi A, Bonifacio M, Cilloni D, Iurlo A, Martinelli G, Rosti G, Stagno F, Fazi P, Vignetti M, Pane F. Breccia M, et al. Among authors: castagnetti f. Clin Lymphoma Myeloma Leuk. 2025 Jan;25(1):e34-e39. doi: 10.1016/j.clml.2024.08.009. Epub 2024 Sep 7. Clin Lymphoma Myeloma Leuk. 2025. PMID: 39322541
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.
Hochhaus A, Wang J, Kim DW, Kim DDH, Mayer J, Goh YT, le Coutre P, Takahashi N, Kim I, Etienne G, Andorsky D, Issa GC, Larson RA, Bombaci F, Kapoor S, McCulloch T, Malek K, Yau L, Ifrah S, Hoch M, Cortes JE, Hughes TP; ASC4FIRST Investigators. Hochhaus A, et al. N Engl J Med. 2024 Sep 12;391(10):885-898. doi: 10.1056/NEJMoa2400858. Epub 2024 May 31. N Engl J Med. 2024. PMID: 38820078 Clinical Trial.
Management and outcome of patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era - analysis of the European LeukemiaNet Blast Phase Registry.
Brioli A, Lomaia E, Fabisch C, Sacha T, Klamova H, Morozova E, Golos A, Ernst P, Olsson-Stromberg U, Zackova D, Nicolini FE, Bao H, Castagnetti F, Patkowska E, Mayer J, Hirschbühl K, Podgornik H, Paczkowska E, Parry A, Ernst T, Voskanyan A, Szczepanek E, Saussele S, Franke GN, Kiani A, Faber E, Krause S, Casado LF, Lewandowski K, Eder M, Anhut P, Gil J, Südhoff T, Hebart H, Heibl S, Pfirrmann M, Hochhaus A, Lauseker M. Brioli A, et al. Among authors: castagnetti f. Leukemia. 2024 May;38(5):1072-1080. doi: 10.1038/s41375-024-02204-y. Epub 2024 Mar 28. Leukemia. 2024. PMID: 38548962 Free PMC article.
The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients: 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment Plan.
Malagola M, Iurlo A, Bucelli C, Abruzzese E, Bonifacio M, Stagno F, Binotto G, D'Adda M, Lunghi M, Crugnola M, Ferrari ML, Lunghi F, Castagnetti F, Rosti G, Lemoli RM, Sancetta R, Coppi MR, Corsetti MT, De Gobbi M, Romano A, Tiribelli M, Russo Rossi A, Russo S, Defina M, Farina M, Bernardi S, Butturini G, Pellizzeri S, Roccaro AM, Russo D. Malagola M, et al. Among authors: castagnetti f. Clin Lymphoma Myeloma Leuk. 2024 May;24(5):323-331. doi: 10.1016/j.clml.2024.01.008. Epub 2024 Jan 25. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38369436 Free article. Clinical Trial.
A Review of the Therapeutic Role of Bosutinib in Chronic Myeloid Leukemia.
Kantarjian HM, Jabbour EJ, Lipton JH, Castagnetti F, Brümmendorf TH. Kantarjian HM, et al. Among authors: castagnetti f. Clin Lymphoma Myeloma Leuk. 2024 May;24(5):285-297. doi: 10.1016/j.clml.2024.01.005. Epub 2024 Jan 12. Clin Lymphoma Myeloma Leuk. 2024. PMID: 38278737 Free article. Review.
Metabolic pseudoprogression in a patient with metastatic KIT exon 11 GIST after 1 month of first-line imatinib: a case report.
Tassinari E, Conci N, Battisti G, Porta F, Di Scioscio V, Pirini MG, de Biase D, Nigro MC, Iezza M, Castagnetti F, Lovato L, Fanti S, Pantaleo MA, Nannini M. Tassinari E, et al. Among authors: castagnetti f. Front Oncol. 2023 Dec 20;13:1310452. doi: 10.3389/fonc.2023.1310452. eCollection 2023. Front Oncol. 2023. PMID: 38188286 Free PMC article.
149 results